MRVI INVESTOR DEADLINE: Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Portfolio Pulse from
Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) for investors who purchased or acquired securities between August 7, 2024, and February 24, 2025. Investors have until May 5, 2025, to seek appointment as lead plaintiff.
March 10, 2025 | 1:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
A class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. for investors who acquired securities during the specified period. The deadline to seek lead plaintiff status is May 5, 2025.
The announcement of a class action lawsuit typically has a negative impact on a company's stock price due to potential legal liabilities and reputational damage. The deadline for investors to seek lead plaintiff status is May 5, 2025, which may keep the issue in the public eye and maintain pressure on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100